These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 13233636)

  • 1. Properties of plasma thromboplastin antecedent (PTA) in relation to blood coagulation.
    ROSENTHAL RL
    J Lab Clin Med; 1955 Jan; 45(1):123-9. PubMed ID: 13233636
    [No Abstract]   [Full Text] [Related]  

  • 2. Human thromboplastic cellular and tissue factors in blood coagulation: lipoprotein release in vivo.
    SHINOWARA GY
    Nihon Ketsueki Gakkai Zasshi; 1961 Dec; 24():716-22. PubMed ID: 13912047
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consumption of antihemophilic globulin and development of thromboplastin-accelerating power in platelet-free plasma diluted 1:5, normal or pathological. Their relation to the conversion of prothrombin].
    MAYER G; MAYER S
    C R Seances Soc Biol Fil; 1961; 155():1687-90. PubMed ID: 14471689
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemophilia and hemophilia-like diseases caused by deficiencies in plasma thromboplastin factors: anti-hemophilic globulin (AHG), plasma thromboplastin component (PTC) and plasma thromboplastin antecedent (PTA).
    ROSENTHAL RL
    Am J Med; 1954 Jul; 17(1):57-69. PubMed ID: 13171395
    [No Abstract]   [Full Text] [Related]  

  • 6. The preparation of plasma thromboplastin antecedent (PTA) and its assay with purified clotting components.
    GALLICK H; HYNDMAN LA; McCALL KB
    Blood; 1960 Mar; 15():404-12. PubMed ID: 13826149
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of intravenous blood thromboplastin intermediates on clotting in rats.
    SPAET TH; KROPATKIN M
    Am J Physiol; 1958 Oct; 195(1):77-80. PubMed ID: 13583126
    [No Abstract]   [Full Text] [Related]  

  • 8. Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma.
    SCHIFFMAN S; RAPAPORT SI; WARE AG; MEHL JW
    Proc Soc Exp Biol Med; 1960 Dec; 105():453-5. PubMed ID: 13747627
    [No Abstract]   [Full Text] [Related]  

  • 9. [HEMORRHAGIC DIATHESIS CAUSED BY A DEFICIENCY OF PLASMA-THROMBOPLASTIN-ANTECEDENT (PTA)].
    DE VRIES SI; BRAAT-VANSTRAATEN MA
    Ned Tijdschr Geneeskd; 1964 Jan; 108():118-27. PubMed ID: 14141156
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma thromboplastin antecedent (PTA) deficiency; clinical, coagulation, therapeutic and hereditary aspects of a new hemophilia-like disease.
    ROSENTHAL RL; DRESKIN OH; ROSENTHAL N
    Blood; 1955 Feb; 10(2):120-31. PubMed ID: 13230164
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activity of the arterial wall in coagulation processes. I. Demonstration of a thromboplastin activity of the arterial wall].
    NERI SERNERI GG; ROSSI FERRINI PL
    Sperimentale; 1961; 111():173-84. PubMed ID: 14479037
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activity of the arterial wall on the processes of coagulation. II. Mechanism of action of the thromboplastin of the arterial wall in coagulative kinetics].
    NERI SERNERI GG; ROSSI FERRINI PL
    Sperimentale; 1961; 111():333-44. PubMed ID: 14479038
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding from deficiency of plasma thromboplastin antecedent (PTA) coagulation factor; report of a case.
    STEGELSKE RF; GORES RJ; HURN MM; OWEN CA
    Oral Surg Oral Med Oral Pathol; 1957 Mar; 10(3):225-9. PubMed ID: 13407915
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum.
    Forbes CD; Ratnoff OD
    J Lab Clin Med; 1972 Jan; 79(1):113-27. PubMed ID: 4257309
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay.
    Saito H; Goldsmith GH
    Blood; 1977 Sep; 50(3):377-85. PubMed ID: 884316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CLINICAL EVALUATION OF PLASMA THROMBOPLASTIN ANTECEDENT (PTA) DEFICIENCY.
    CONRAD FG; BRENEMAN WL; GRISHAM DB
    Ann Intern Med; 1965 May; 62():885-98. PubMed ID: 14283388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood coagulation in C avitaminosis. Part II. The change in the prothrombin and thrombotropin concentration and causes of decreased thromboplastin activity of the blood in C avitaminosis in guinea pigs].
    ANDREENKO GV; SYTINA NP
    Biull Eksp Biol Med; 1960 Mar; 49():30-5. PubMed ID: 13793532
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma thromboplastin antecedent (PTA) activity.
    ROSENTHAL RL
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():379-83. PubMed ID: 13974994
    [No Abstract]   [Full Text] [Related]  

  • 19. Assay of plasma thromboplastin antecedent (PTA) with artificially depleted normal plasma.
    HOROWITZ HI; WILCOX WP; FUJIMOTO MM
    Blood; 1963 Jul; 22():35-43. PubMed ID: 13954981
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.
    Saito H; Ratnoff OD; Marshall JS; Pensky J
    J Clin Invest; 1973 Apr; 52(4):850-61. PubMed ID: 4266422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.